tiprankstipranks
Advertisement
Advertisement

Marker Therapeutics Sets Date for 2026 Annual Meeting

Story Highlights
  • Marker Therapeutics set May 1, 2026 for its advanced 2026 annual shareholder meeting.
  • The company set March 9, 2026 as the deadline for shareholder proposals for the proxy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Marker Therapeutics Sets Date for 2026 Annual Meeting

Claim 55% Off TipRanks

The latest announcement is out from Marker Therapeutics ( (MRKR) ).

On February 9, 2026, Marker Therapeutics, Inc. announced that its Board of Directors had set May 1, 2026 as the date for the company’s 2026 Annual Meeting of Stockholders, a move that advances the meeting more than 30 days from the prior year’s schedule and triggers specific disclosure requirements under securities regulations. As a result, the company established March 9, 2026 as the new deadline for stockholder proposals to be included in the 2026 proxy materials and directed investors to submit such proposals to its Houston corporate offices, with the record date, time and location of the meeting to be detailed in the forthcoming proxy statement.

The most recent analyst rating on (MRKR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Marker Therapeutics stock, see the MRKR Stock Forecast page.

Spark’s Take on MRKR Stock

According to Spark, TipRanks’ AI Analyst, MRKR is a Neutral.

The score is held back primarily by weak financial performance (declining revenue, very negative margins, and ongoing cash burn), despite the benefit of zero debt. Technical indicators are a key support, showing strong momentum with price above major moving averages and a positive MACD. Valuation contributes modestly negatively because the negative P/E reflects continued losses and there is no dividend yield data.

To see Spark’s full report on MRKR stock, click here.

More about Marker Therapeutics

Marker Therapeutics, Inc. is a biopharmaceutical company. It operates in the life sciences industry and focuses on developing therapeutic products, with its activities overseen by a Board of Directors and governed through regular annual meetings of stockholders as part of its public-company corporate governance framework.

Average Trading Volume: 394,427

Technical Sentiment Signal: Hold

Current Market Cap: $27.51M

Learn more about MRKR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1